Piramal Enterprises Limited (PEL)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
1921.35
15.8(0.83%)

Piramal Enterprises Limited operates in financial services and pharmaceuticals businesses in India, North America, Europe, Japan, and internationally. It operates through Pharmaceuticals Manufacturing and Services, and Financial Services segments. The company provides housing finance and other financing solutions, such as private equity, structured debt, senior secured debt, construction finance, and flexi lease rental discounting to real estate sector; and funding solutions to infrastructure, renewable energy, roads, industrials, auto components, and other sectors. It also operates distressed asset investing platform that invests in equity and/or debt in assets. In addition, the company offers contract development and manufacturing solutions, including drug discovery, production, and manufacturing of active pharmaceutical ingredients and formulations; and inhalation and injectable anaesthesia, injectable pain, antibiotics, and other medications, as well as intrathecal spasticity management drugs. Further, it provides over-the-counter products comprising analgesics, skin care, kids' wellness, digestives, women's health, disinfectant, Covifind, and hygiene and protection products, as well as vitamins, minerals, and supplements primarily under the Saridon, Lacto Calamine, Little's, I-Pill, Supradyn, Polycrol, Triactiv, Ourdaily, Pulse Oximeters, and Tetmosol brands. The company was formerly known as Piramal Healthcare Limited and changed its name to Piramal Enterprises Limited in July 2012. Piramal Enterprises Limited was incorporated in 1947 and is based in Mumbai, India.

Pricing Updates

TODAY'S HIGH

1927

TODAY'S LOW

1889

52 WEEK HIGH

3014.95

52 WEEK LOW

1560.1

Major Holders

% of Shares Held by
All Insider

47.43%

% of Shares Held by
Institutions

31.48%

% of Float Held by
Institutions

59.89%

Number of Institutions
Holding Shares

133

Company Overview

MARKET CAP

45855.70 Cr.

ETERPRISE VALUE

93042 Cr.

NO. OF SHARES

23.86 Cr.

BOOK VALUE

1486.993

DIV. YIELD

33%

DEBT

55702.95 Cr.

GROSS PROFIT

11760.79 Cr.

CASH

9864.37 Cr.

REVENUE

15205.56 Cr.

REVENUE/SHARE

637.156

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments1158.72 Cr.-1505.62 Cr.1898.33 Cr.-364.15 Cr.
Change To Liabilities144.42 Cr.183.95 Cr.171.26 Cr.152.50 Cr.
Total cashflows from Investing Activities-2226.18 Cr.-2772.25 Cr.7468.69 Cr.-826.51 Cr.
Net Borrowings-6166.12 Cr.-648.56 Cr.-14915.40 Cr.12272.12 Cr.
Total Cash from Financing Activities-6987.97 Cr.2071.58 Cr.-13018.56 Cr.10751.82 Cr.
Other Liabilities5807.54 Cr.3132.27 Cr.4707.33 Cr.-15774.52 Cr.
Total Assets199.67 Cr.199.67 Cr.3480.95 Cr.6.87 Cr.
Net Income1923.11 Cr.1332.34 Cr.24.03 Cr.1467.06 Cr.
Change in Cash699.98 Cr.2970.07 Cr.1988.34 Cr.-1679.38 Cr.
Effect of Exchange Rate-2.05 Cr.-4.22 Cr.21.87 Cr.12.18 Cr.
Total Cash from Operating Activities8749.59 Cr.3664.54 Cr.7516.34 Cr.-11611.16 Cr.
Depreciation665.78 Cr.543.37 Cr.570.07 Cr.427.29 Cr.
Other Cashflows from Investing Activities283.48 Cr.208.34 Cr.253.51 Cr.250.53 Cr.
Dividends Paid-797.59 Cr.-315.75 Cr.-556.73 Cr.-448.23 Cr.
Change to Inventory-253.18 Cr.-231.24 Cr.-304.42 Cr.-69 Cr.
Change to Account Receivables-56.08 Cr.-238.57 Cr.-159.02 Cr.-105.96 Cr.
Other Cashflows from Financing Activities-223.93 Cr.2960.89 Cr.-1027.38 Cr.-1078.94 Cr.
Change to Net Income206.74 Cr.1064.20 Cr.2399.64 Cr.972.11 Cr.
Capital Expenditures-958.42 Cr.-595.18 Cr.-470.66 Cr.-691.90 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax2509.56 Cr.3455.77 Cr.1407.12 Cr.2541.84 Cr.
Minority Interest1347.78 Cr.1121 Cr.1121 Cr.9.03 Cr.
Net Income6504.55 Cr.7089.45 Cr.6205.21 Cr.7100.05 Cr.
Selling General Administrative2135.01 Cr.1800.37 Cr.1772.93 Cr.1707.45 Cr.
Gross Profit12182.42 Cr.10857.39 Cr.11547.45 Cr.10528.52 Cr.
Ebit6504.55 Cr.7089.45 Cr.6205.21 Cr.7100.05 Cr.
Operating Income6504.55 Cr.7089.45 Cr.6205.21 Cr.7100.05 Cr.
Other Operating Expenses2877.08 Cr.1406.67 Cr.3047.69 Cr.1303.18 Cr.
Interest Expense-4479.87 Cr.-4088.53 Cr.-5062.51 Cr.-3994.06 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense510.79 Cr.2042.91 Cr.1960.43 Cr.852.22 Cr.
Total Revenue14713.41 Cr.12977.16 Cr.13400.84 Cr.12192.20 Cr.
Total Operating Expenses8208.86 Cr.5887.71 Cr.7195.63 Cr.5092.15 Cr.
Cost of Revenue2530.99 Cr.2119.77 Cr.1853.39 Cr.1663.68 Cr.
Total Other Income Expense Net-3994.99 Cr.-3633.68 Cr.-4798.09 Cr.-4558.21 Cr.
Discontinued Operations00574.45 Cr.-225.53 Cr.
Net Income from Continuous Ops.1998.77 Cr.1412.86 Cr.-553.31 Cr.1689.62 Cr.
Net Income Applicable to Common Shares1923.11 Cr.1332.34 Cr.24.03 Cr.1467.06 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets3377.75 Cr.2757.01 Cr.2912.84 Cr.3094.46 Cr.
Capital Surplus012946.74 Cr.9697.25 Cr.2944.50 Cr.
Total Liabilities63036 Cr.41979.90 Cr.44336.99 Cr.58380.15 Cr.
Stock Holder Equity35489.13 Cr.34017.96 Cr.30571.59 Cr.27224.27 Cr.
Minority Interest1347.78 Cr.1121 Cr.09.03 Cr.
Other Liabilities5242.74 Cr.512.82 Cr.569.83 Cr.736.96 Cr.
Total Assets99872.91 Cr.77118.86 Cr.74908.58 Cr.85613.45 Cr.
Common Stock47.73 Cr.45.11 Cr.45.11 Cr.36.89 Cr.
Retained Earnings018764.82 Cr.18062.48 Cr.17379.35 Cr.
Other Liabilities394.21 Cr.395.50 Cr.213.54 Cr.263.42 Cr.
Good Will1294.70 Cr.1114.28 Cr.1139.07 Cr.5939.45 Cr.
Treasury Stock35441.40 Cr.2261.29 Cr.2766.75 Cr.6863.53 Cr.
Other Assets44599.32 Cr.31549.95 Cr.35370.52 Cr.38362.27 Cr.
Cash7184.75 Cr.5719.01 Cr.4340.94 Cr.811.73 Cr.
Current Liabilities18699.88 Cr.13347.25 Cr.23673 Cr.31083.66 Cr.
Long Term Asset Charges1367.91 Cr.937.24 Cr.2372.32 Cr.4068.45 Cr.
Short Long Term Debt11672.64 Cr.7909.95 Cr.13798.38 Cr.13425.22 Cr.
Other Stockholder Equity35441.40 Cr.2261.29 Cr.2766.75 Cr.6863.53 Cr.
Property Plant Equipment4313.74 Cr.3327.10 Cr.2880.67 Cr.2656.78 Cr.
Total Cur. Assets24312.47 Cr.19867.42 Cr.16113.08 Cr.12261.02 Cr.
Long Term Investments21974.93 Cr.18503.10 Cr.16492.40 Cr.23299.47 Cr.
Net Tangible Assets30816.68 Cr.30146.67 Cr.26519.68 Cr.18190.36 Cr.
Short Term Investments2881.59 Cr.1709.93 Cr.2723.27 Cr.1634.36 Cr.
Net Receivables10599.27 Cr.6640.66 Cr.5444.20 Cr.6719.82 Cr.
Long Term Debt43778.36 Cr.28096.76 Cr.20306.25 Cr.27033.07 Cr.
Inventory1533.01 Cr.1299.23 Cr.1061.17 Cr.831.33 Cr.
Accounts Payable1696.09 Cr.1178.39 Cr.989.83 Cr.960.87 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account